Thioctic acid
ALIMENTARY TRACT AND METABOLISM
Also known as: (RS)-Lipoic acid, alpha lipoic acid, alpha-lipoic acid, lipoic acid, lipothion, thioctacid, thioctsan, tioctacid
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Thioctic acid is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including ACHE, glmU and SAE1|UBA2. Recorded indications include Diabetic peripheral neuropathy.
- Molecular targets: ACHE, glmU, SAE1|UBA2 and TARDBP (4 listed in DrugCentral).
- Indications: Diabetic peripheral neuropathy.
- ATC code: A16AX01 (Various alimentary tract and metabolism products).
- Molecular formula: C8H14O2S2; molecular weight 206.32 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Diabetic peripheral neuropathy
Contraindications (3)
- Disease of liver
- Low blood pressure
- Obstruction of bile duct
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Acetylcholinesterase | ACHE | unknown | IC50 9.00 |
| Bifunctional protein GlmU | glmU | unknown | IC50 5.41 |
| SUMO-activating enzyme | SAE1|UBA2 | unknown | IC50 5.32 |
| TAR DNA-binding protein 43 | TARDBP | unknown | IC50 4.70 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A16AX01 | ALIMENTARY TRACT AND METABOLISM › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › Various alimentary tract and metabolism products |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Hepatic necrosis | 167.9 |
| Hepatic encephalopathy | 134.4 |
| Hepatotoxicity | 118.0 |
| Hepatic cirrhosis | 105.5 |
| Drug-induced liver injury | 102.0 |
| Drug interaction | 74.7 |
| Basal cell carcinoma | 58.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Thioctic acid is on its molecule page.
| Molecular formula | C8H14O2S2 |
|---|---|
| Molecular weight | 206.32 g/mol |
| CAS number | 1077-28-7 |
| InChIKey | AGBQKNBQESQNJD-UHFFFAOYSA-N |
| PubChem CID | 864 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Thioctic acid used for?
DrugCentral lists the following indications for Thioctic acid: Diabetic peripheral neuropathy.
How does Thioctic acid work?
Its molecular targets in DrugCentral include ACHE, glmU, SAE1|UBA2 and TARDBP.
What is the chemical formula of Thioctic acid?
Thioctic acid has the molecular formula C8H14O2S2 and a molecular weight of 206.32 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4732 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL134342 — compound record and bioactivity
- PubChem CID 864 — chemical identifiers
- DrugBank DB00166 — drug record
- FDA UNII 73Y7P0K73Y — substance identity
- DailyMed: FDA labels for Thioctic acid — current prescribing information (label search)
- UniProt P22303 (ACHE) — target protein
- UniProt Q13148 (TARDBP) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.